Analytical Performance and Concordance with Next-Generation Sequencing of a Rapid, Multiplexed dPCR Panel for the Detection of DNA and RNA Biomarkers in Non-Small-Cell Lung Cancer

FDA approval of targeted therapies for lung cancer has significantly improved patient survival rates. Despite these improvements, barriers to timely access to biomarker information, such as nucleic acid input, still exist. Here, we report the analytical performance and concordance with next-generati...

Descripción completa

Detalles Bibliográficos
Autores principales: Cabrera, Kerri, Gole, Jeffrey, Leatham, Bryan, Springer, Matthew J., Smith, Molly, Herdt, Leah, Jacky, Lucien, Brown, Bradley A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10650055/
https://www.ncbi.nlm.nih.gov/pubmed/37958195
http://dx.doi.org/10.3390/diagnostics13213299

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10650055/
https://www.ncbi.nlm.nih.gov/pubmed/37958195
http://dx.doi.org/10.3390/diagnostics13213299

Ejemplares similares